8.04 USD
+0.09 (+1.13%)
8.04 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to KMDA. KMDA was compared to 530 industry peers in the Biotechnology industry. While KMDA has a great profitability rating, there are some minor concerns on its financial health. KMDA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make KMDA suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
In the past year KMDA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
KMDA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
KMDA's Return On Assets of 5.42% is amongst the best of the industry. KMDA outperforms 91.89% of its industry peers.
With an excellent Return On Equity value of 7.72%, KMDA belongs to the best of the industry, outperforming 91.51% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.67%, KMDA belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KMDA is significantly below the industry average of 18.28%.
The last Return On Invested Capital (6.67%) for KMDA is above the 3 year average (2.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROIC | 6.67% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 11.70%, KMDA belongs to the top of the industry, outperforming 91.70% of the companies in the same industry.
In the last couple of years the Profit Margin of KMDA has declined.
Looking at the Operating Margin, with a value of 15.89%, KMDA belongs to the top of the industry, outperforming 93.58% of the companies in the same industry.
KMDA's Operating Margin has declined in the last couple of years.
The Gross Margin of KMDA (43.75%) is better than 74.53% of its industry peers.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for KMDA has been increased compared to 1 year ago.
Compared to 5 years ago, KMDA has more shares outstanding
The debt/assets ratio for KMDA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.57 indicates that KMDA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.57, KMDA is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
KMDA has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
KMDA's Debt to FCF ratio of 0.59 is amongst the best of the industry. KMDA outperforms 95.09% of its industry peers.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.04, KMDA perfoms like the industry average, outperforming 42.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 3.57 |
ROIC/WACC0.78
WACC8.52%
2.3 Liquidity
A Current Ratio of 4.02 indicates that KMDA has no problem at all paying its short term obligations.
KMDA has a Current ratio (4.02) which is in line with its industry peers.
KMDA has a Quick Ratio of 2.25. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
KMDA has a worse Quick ratio (2.25) than 70.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.57% over the past year.
KMDA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.60% yearly.
Looking at the last year, KMDA shows a quite strong growth in Revenue. The Revenue has grown by 10.36% in the last year.
Measured over the past years, KMDA shows a small growth in Revenue. The Revenue has been growing by 4.82% on average per year.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
The Earnings Per Share is expected to grow by 29.48% on average over the next years. This is a very strong growth
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.31% on average per year.
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
KMDA is valuated rather expensively with a Price/Earnings ratio of 22.33.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.53% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.19, KMDA is valued at the same level.
Based on the Price/Forward Earnings ratio of 17.78, the valuation of KMDA can be described as rather expensive.
Based on the Price/Forward Earnings ratio, KMDA is valued cheaply inside the industry as 94.91% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, KMDA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.33 | ||
| Fwd PE | 17.78 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, KMDA is valued cheaper than 97.36% of the companies in the same industry.
94.34% of the companies in the same industry are more expensive than KMDA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.73 | ||
| EV/EBITDA | 9.24 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KMDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as KMDA's earnings are expected to grow with 29.48% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
5. Dividend
5.1 Amount
KMDA has a Yearly Dividend Yield of 2.84%. Purely for dividend investing, there may be better candidates out there.
KMDA's Dividend Yield is rather good when compared to the industry average which is at 1.20. KMDA pays more dividend than 98.68% of the companies in the same industry.
KMDA's Dividend Yield is a higher than the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
5.2 History
KMDA does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
8.04
+0.09 (+1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.42%
Inst Owner Change0%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap463.75M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (64.93%)
Short Float %0.24%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.84% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)-11.86%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)2.08%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.33 | ||
| Fwd PE | 17.78 | ||
| P/S | 2.65 | ||
| P/FCF | 24.73 | ||
| P/OCF | 15.99 | ||
| P/B | 1.75 | ||
| P/tB | 1.97 | ||
| EV/EBITDA | 9.24 |
EPS(TTM)0.36
EY4.48%
EPS(NY)0.45
Fwd EY5.62%
FCF(TTM)0.33
FCFY4.04%
OCF(TTM)0.5
OCFY6.25%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.51
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROCE | 8.44% | ||
| ROIC | 6.67% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 9.66% | ||
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.73% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 67.04% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 35.6 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 91.69% | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.57 |
F-Score7
WACC8.52%
ROIC/WACC0.78
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
What is the valuation status for KMDA stock?
ChartMill assigns a valuation rating of 7 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
How financially healthy is KAMADA LTD?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.